Heart failure medication titration plan (PDF, 139MB)
The heart failure medication titration plan is a communication tool (initiated by the treating team) that can improve up-titration of medications1. The plan provides suggestions for monitoring, scheduling titration dose, and a flexible diuretic regime. To save confusion, a clinician is nominated to manage the titration (e.g. GP, consultant, nurse practitioner). Regardless of who is managing the titration, the plan should be sent to the GP.
1 Hickey A, Suna J, Marquart L et al. Improving medication titration in heart failure by embedding a structured medication titration plan. Int J Cardiol 2016;224:99-106.
Sacubitril/valsartan (Entresto) Fact Sheet (PDF, 267kB)
The sacubitril-valsartan (Entresto) fact sheet provides prescribing information for a new drug class called angiotensin receptor-neprilysin inhibitor (ARNI). The Pharmaceutical Benefits Scheme (PBS) recommends Entresto for heart failure patients with a reduced ejection fraction.
The HEART online toolkit provides nurses, allied health, pharmacists and doctors with evidence-based resources to assist the management of patients with chronic heart failure and cardiovascular disease.
Heart Failure: End-stage management guideline (PDF, 536kB)
The Queensland Health end-stage heart failure management guideline will help the health care team to recognise when a patient is approaching end-stage heart failure. The guide provides advice on how to promote quality of life and includes approaches to medication management, implantable cardiac defibrillator (ICD) deactivation, and managing common symptoms (dyspnoea, oedema, pain, anxiety and depression, constipation, nausea and vomiting, anorexia and cachexia, and fatigue).